Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X842 vs lansoprazole for erosive reflux esophagitis
CTR20210736Phase 3Completed
- Sponsor
- Tairui Shengnuo
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linaprazan glurate in erosive esophagitis (EE), sponsored by Tairui Shengnuo. Started Apr 2021; status: completed.
02
Drugs
linaprazan glurate
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on CTR20210736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210736.